NASDAQ:LFMD

LifeMD (LFMD) Stock Forecast, Price & News

$2.18

+0.01 (+0.46%)

(As of 05/26/2023 03:59 PM ET)

Compare

Today's Range: $2.06
▼
$2.20
50-Day Range: $1.15
▼
$2.18
52-Week Range: $1.14
▼
$3.22

Volume: 84,400 shs
Average Volume: 96,886 shs
Market Capitalization: $70.65 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.00

LifeMD MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 221.1% Upside
$7.00 Price Target
Short Interest: Bearish
7.73% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.10
Based on 6 Articles This Week
Insider Trading: Acquiring Shares
$59,678 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.88 out of 5 stars

Medical Sector

741st out of 1,010 stocks

Offices & Clinics Of Medical Doctors Industry

5th out of 7 stocks

3.5

Analyst's Opinion

Consensus Rating
LifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $7.00, LifeMD has a forecasted upside of 221.1% from its current price of $2.18.
Amount of Analyst Coverage
LifeMD has only been the subject of 1 research reports in the past 90 days.

0.0

Short Interest

Percentage of Shares Shorted
7.73% of the float of LifeMD has been sold short.
Short Interest Ratio / Days to Cover
LifeMD has a short interest ratio ("days to cover") of 19.4, which indicates bearish sentiment.
Change versus previous month
Short interest in LifeMD has recently increased by 0.51%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
LifeMD does not currently pay a dividend.
Dividend Growth
LifeMD does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for LFMD.

3.9

News and Social Media Coverage

News Sentiment
LifeMD has a news sentiment score of 1.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for LifeMD this week, compared to 1 article on an average week.
Search Interest
6 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
MarketBeat Follows
2 people have added LifeMD to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, LifeMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $59,678.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
18.89% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 17.01% of the stock of LifeMD is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of LifeMD is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of LifeMD is -1.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About LifeMD (NASDAQ:LFMD) Stock

LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The firm combines virtual medical treatment with prescription medications and over-the-counter products. It operates through the Telehealth and WorkSimpli segments. The company was founded in 1987 and is headquartered in New York, NY.

Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Stock News Headlines

May 27, 2023 | americanbankingnews.com

Insider Buying: LifeMD, Inc. (NASDAQ:LFMD) CEO Acquires 17,664 Shares of Stock

May 25, 2023 | americanbankingnews.com

Stefan Galluppi Buys 10,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) Stock

May 29, 2023 | Legacy Research (Affiliate) (Ad)

Sell every Stock except ONE

Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...

May 23, 2023 | finance.yahoo.com

LifeMD, Inc. to Present at the June 1st Virtual Investor Summit

May 12, 2023 | marketwatch.com

LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA

May 11, 2023 | markets.businessinsider.com

LifeMD earnings: here's what Wall Street expects

May 10, 2023 | americanbankingnews.com

LifeMD (LFMD) Set to Announce Quarterly Earnings on Friday

May 3, 2023 | finance.yahoo.com

LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023

May 29, 2023 | Legacy Research (Affiliate) (Ad)

Sell every Stock except ONE

Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...

April 24, 2023 | finance.yahoo.com

LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare

March 26, 2023 | americanbankingnews.com

BTIG Research Trims LifeMD (NASDAQ:LFMD) Target Price to $7.00

March 22, 2023 | finance.yahoo.com

LifeMD, Inc. Announces Closing of New $40 Million Credit Facility

March 21, 2023 | americanbankingnews.com

LifeMD (LFMD) Set to Announce Earnings on Wednesday

March 7, 2023 | finance.yahoo.com

LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023

February 10, 2023 | finance.yahoo.com

LifeMD Appoints Dr. Joan LaRovere to its Board of Directors

January 4, 2023 | finance.yahoo.com

LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary Care

November 22, 2022 | finance.yahoo.com

LifeMD, Inc. Ranked Number 140 Fastest Growing Company on Deloitte’s 2022 North America Technology Fast 500™

November 18, 2022 | finance.yahoo.com

LifeMD, Inc. to Participate in Upcoming Investor Conferences

November 15, 2022 | markets.businessinsider.com

BTIG Keeps Their Buy Rating on LifeMD (LFMD)

November 10, 2022 | finance.yahoo.com

LifeMD, Inc. Reports Third Quarter 2022 Results

October 26, 2022 | finance.yahoo.com

LifeMD, Inc. to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 10, 2022

September 20, 2022 | marketscreener.com

LIFEMD, INC. : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

September 20, 2022 | marketscreener.com

LifeMD : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.com

September 20, 2022 | globenewswire.com

LifeMD Appoints Bobby Jindal to the Board of Directors - GlobeNewswire

September 20, 2022 | finance.yahoo.com

LifeMD Appoints Bobby Jindal to the Board of Directors

September 15, 2022 | marketscreener.com

LIFEMD, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

September 14, 2022 | finance.yahoo.com

LifeMD Expands Primary Care Platform’s Diagnostic Capabilities with New At-Home Screening Kits For Early Warning Signs Of Cancer - Yahoo Finance

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMD Company Calendar

Last Earnings: 3/22/2023
Today: 5/29/2023
Next Earnings (Estimated): 8/10/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Offices & clinics of medical doctors
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:LFMD
CUSIP: N/A
CIK: 948320
Web: www.lifemd.com
Phone: (866) 351-5907
Fax: N/A
Employees: 196
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $7.00
High Stock Price Forecast: $7.00
Low Stock Price Forecast: $7.00
Forecasted Upside/Downside: +221.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.26)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-45,540,000.00
Net Margins: -29.44%
Pretax Margin: -28.29%
Return on Equity: -7,255.81%
Return on Assets: -67.31%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.71
Quick Ratio: 0.58

Sales & Book Value

Annual Sales: $119.03 million
Price / Sales: 0.59
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.38) per share
Price / Book: -5.74

Miscellaneous

Outstanding Shares: 32,410,000
Free Float: 26,289,000
Market Cap: $70.65 million
Optionable: Optionable
Beta: 1.30

Key Executives

Justin Schreiber
Chairman & Chief Executive Officer

Alexander Mironov
President

Brad Roberts
Chief Operating Officer

Marc David Benathen
Chief Financial Officer

Stefan Galluppi
Director & Chief Innovation Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

LFMD Stock - Frequently Asked Questions

Should I buy or sell LifeMD stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LifeMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" LFMD shares.
View LFMD analyst ratings or view top-rated stocks.
What is LifeMD's stock price forecast for 2023?: 1 Wall Street analysts have issued 1-year price targets for LifeMD's shares. Their LFMD share price forecasts range from $7.00 to $7.00. On average, they expect the company's share price to reach $7.00 in the next year. This suggests a possible upside of 221.1% from the stock's current price.
View analysts price targets for LFMD or view top-rated stocks among Wall Street analysts.
How have LFMD shares performed in 2023?: LifeMD's stock was trading at $1.94 at the start of the year. Since then, LFMD stock has increased by 12.4% and is now trading at $2.18.
View the best growth stocks for 2023 here.
When is LifeMD's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our LFMD earnings forecast.
How were LifeMD's earnings last quarter?: LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings results on Wednesday, March, 22nd. The company reported ($0.40) EPS for the quarter. The business earned $28.12 million during the quarter. LifeMD had a negative trailing twelve-month return on equity of 7,255.81% and a negative net margin of 29.44%.
What guidance has LifeMD issued on next quarter's earnings?: LifeMD updated its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $35.00 million-$36.00 million, compared to the consensus revenue estimate of $35.70 million.

What is LifeMD's stock symbol?: LifeMD trades on the NASDAQ under the ticker symbol "LFMD."
Who are LifeMD's major shareholders?: LifeMD's stock is owned by a number of retail and institutional investors. Top institutional investors include Royce & Associates LP (3.36%), Royce & Associates LP (3.30%), B. Riley Financial Inc. (2.84%), BlackRock Inc. (1.17%), HighTower Advisors LLC (0.36%) and JPMorgan Chase & Co. (0.27%). Insiders that own company stock include Bertrand Velge, Brad Michael Roberts, Corey Deutsch, Eric Harold Yecies, Happy David Walters, Joseph Ditrolio, Justin Schreiber, Marc David Benathen, Naveen Bhatia and Stefan Galluppi.
View institutional ownership trends.
How do I buy shares of LifeMD?: Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is LifeMD's stock price today?: One share of LFMD stock can currently be purchased for approximately $2.18.
How much money does LifeMD make?: LifeMD (NASDAQ:LFMD) has a market capitalization of $70.65 million and generates $119.03 million in revenue each year. The company earns $-45,540,000.00 in net income (profit) each year or ($1.26) on an earnings per share basis.
How many employees does LifeMD have?: The company employs 196 workers across the globe.
How can I contact LifeMD?: LifeMD's mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The official website for the company is www.lifemd.com. The company can be reached via phone at (866) 351-5907 or via email at cdeutsch@lifemd.com.

This page (NASDAQ:LFMD) was last updated on 5/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial